Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$1.46 - $2.45 $2,978 - $4,998
-2,040 Reduced 16.74%
10,145 $21,000
Q4 2021

Feb 14, 2022

SELL
$2.13 - $3.46 $5,197 - $8,442
-2,440 Reduced 16.68%
12,185 $28,000
Q3 2021

Nov 15, 2021

SELL
$3.14 - $3.9 $3,768 - $4,680
-1,200 Reduced 7.58%
14,625 $51,000
Q2 2021

Aug 16, 2021

SELL
$3.8 - $4.56 $4,313 - $5,175
-1,135 Reduced 6.69%
15,825 $61,000
Q1 2021

May 17, 2021

BUY
$4.33 - $6.63 $24,655 - $37,751
5,694 Added 50.54%
16,960 $78,000
Q4 2020

Feb 12, 2021

BUY
$4.87 - $17.29 $54,865 - $194,789
11,266 New
11,266 $69,000

Others Institutions Holding ASMB

# of Institutions
1
Shares Held
16.3K
Call Options Held
0
Put Options Held
0

About ASSEMBLY BIOSCIENCES, INC.


  • Ticker ASMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,436,900
  • Market Cap $737M
  • Description
  • Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...
More about ASMB
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.